This site uses cookies to improve user experience by collecting data. By continuing to use this website, you agree to the use of cookies and similar technologies as described in our Privacy Policy.
CONFIRM
Collaborating for Next Generation Cell Therapies

Acepodia is actively seeking partners who are interested in collaborating to develop innovative and highly effective cell therapies for patients with cancer and other diseases with unmet medical needs. We believe our ACC technologies can significantly advance the field of cellular therapeutics through directing allogeneic effector cells by conjugated antibodies. Furthermore, CD16 expression confers our proprietary γδ2T cells with ADCC activity, which leverage the efficacy of clinically used mAb.

Join us if you share our vision

Acepodia is committed to delivering innovative and highly effective cell therapies for patients with cancer.
To discuss partnering with Acepodia, please contact: info@acepodiabio.compartnership